Reason for request
Re-assessment of the actual benefit at the request of the Transparency
Clinical Benefit
| Low |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
ceBjZH641HYSVHkq
